Wegovy (Semaglutide) Weight Loss Injection – Transform Your Weight Loss Journey
Wegovy, developed by Novo Nordisk, is a cutting-edge weight loss solution available via prescription. This injectable pen is specifically designed for adults struggling with obesity or excess weight, especially those with related health concerns.

How Wegovy Works:
Active Ingredient: Wegovy contains semaglutide, a synthetic GLP-1 analog. Semaglutide mimics the action of GLP-1, a natural hormone that helps regulate appetite, insulin release, and glucagon secretion. By enhancing feelings of fullness and reducing appetite, Wegovy supports effective weight management.

Usage: Administered as a convenient once-weekly injection, Wegovy simplifies your weight loss regimen and integrates seamlessly into your lifestyle.

Benefits of Wegovy:

Proven Efficacy: Clinical studies demonstrate that Wegovy significantly aids in weight loss and improves overall well-being. For optimal results, combine Wegovy with a balanced diet and regular physical activity.

Convenience: The weekly injection schedule ensures ease of use, making it easier to maintain your weight loss plan.

Dosage: One injection per week.

Experience a transformative approach to weight loss with Wegovy. For more information or to place an order, visit Bliss Pharmacy today.

Wegovy is delivered through a subcutaneous injection method. Normally, a qualified healthcare professional offers guidance on the recommended dosage and how to administer it. Typically, Wegovy treatment begins with a lower dose, and then the dosage is gradually increased over a few weeks. It's vital to strictly adhere to the healthcare provider's instructions to ensure safety and achieve the best possible results.

*UPDATE: 7.2mg dose is currently only available as 3 x 2.4mg pens and therefore patients will need to inject 3 doses at the same time.  Please ensure you rotate the area or leave at least 5cm between the injections.

WEGOVY® injection is a sterile, aqueous, clear, colorless solution. Each 0.5 mL single-dose pen contains a solution of WEGOVY® containing 0.25 mg, 0.5 mg or 1 mg of semaglutide; and each 0.75mL single-dose pen contains a solution of WEGOVY® containing 1.7, 2.4 mg or 7.2 mg of semaglutide.

Each 0.5 mL single-dose prefilled syringe contains a solution of WEGOVY® containing 0.25 mg, 0.5mg or 1 mg of semaglutide; and each 0.75 mL single-dose prefilled syringe contains a solution of WEGOVY® containing 1.7, 2.4 mg of semaglutide.

Each 1 mL of WEGOVY® contains the following inactive ingredients: disodium phosphate dihydrate, 1.42 mg; sodium chloride, 8.25 mg; and water for injection. WEGOVY® has a pH of approximately 7.4. Hydrochloric acid or sodium hydroxide maybe added to adjust pH.

Each 3 mL prefilled single-patient-use pen contains semaglutide 9.6 mg (3.2 mg/mL), which provides 4 doses of 2.4 mg semaglutide per 0.75 mL.

Each 1 mL of WEGOVY® FlexTouch® solution also contains the following inactive ingredients: disodium phosphate dihydrate, 1.42 mg; phenol, 5.5 mg; propylene glycol, 14 mg; and water for injections. WEGOVY® has a pH of approximately 7.4. Hydrochloric acid or sodium hydroxide may be added to adjust pH.

Each single-patient-use WEGOVY® FlexTouch® Pen contains additional volume to allow for device priming.

Like any medication, Wegovy may have associated side effects. Common side effects might encompass nausea, vomiting, diarrhea, and a decreased appetite. Generally, these effects are temporary and tend to ameliorate with time. Nevertheless, it's crucial to acknowledge that individual reactions may differ. If you encounter severe or persistent side effects, it is advisable to promptly seek guidance from a healthcare professional.

1. Contraindications: Wegovy is not suitable for individuals with a previous hypersensitivity to semaglutide or its constituents. It is not intended for use by individuals with a personal or familial history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

2. Gastrointestinal Disorders: Those with a history of gastrointestinal conditions like inflammatory bowel disease or gastroparesis should exercise caution when considering Wegovy use, as it could potentially worsen these ailments.

3. Kidney Function: Special attention is needed for individuals with impaired kidney function, as Wegovy's elimination from the body may be affected by kidney health. It is advisable to consult a healthcare professional for appropriate dosage adjustments.

4. Pregnancy and Breastfeeding: Wegovy is not recommended during pregnancy or breastfeeding. It is advisable to consult a healthcare provider to explore suitable weight management options in such circumstances.

Download patient information leaflet (PIL) on the link below:

https://www.wegovy.co.uk/content/dam/nn_core/true-blue/wegovy-co-uk/pdf-file/Wegovy-7-2-mg-Patient-Guide.pdf 

Is Wegovy FlexTouch a standalone treatment for weight loss?
Wegovy FlexTouch is most effective when used alongside a reduced-calorie meal plan and increased physical activity. It is not advisable to solely depend on the medication for weight loss without incorporating lifestyle change

Are there any dietary restrictions when using Wegovy FlexTouch?
Although there are no specific dietary restrictions, it is crucial to adhere to a balanced and nutritious meal plan as recommended by your healthcare provider. The best outcomes are typically attained when Wegovy FlexTouch is employed in conjunction with a wholesome eating regimen.

Can I switch to Wegovy FlexTouch if I'm already taking other weight loss medications?
Before making any changes to your medication regimen, it is essential to consult your doctor. They will evaluate your specific health condition and decide whether transitioning to Wegovy FlexTouch is a suitable and safe option for you.

How long does it take to see noticeable results with Wegovy FlexTouch?
The timeframe for observing results can vary from person to person. Some individuals may begin experiencing weight loss within a few weeks of using Wegovy FlexTouch, while others may require more time. Consistency in medication use, combined with a healthy lifestyle, plays a crucial role in achieving and maintaining weight loss.

Can individuals with pre-existing medical conditions use Wegovy FlexTouch?
Before initiating Wegovy FlexTouch, it is essential to inform your healthcare provider about any pre-existing medical conditions you may have, such as heart disease, kidney problems, or pancreatitis. Your doctor will review your medical history and determine the safety of using Wegovy FlexTouch in your specific case.